4.3 Review

Regulatory mechanisms of sclerostin expression during bone remodeling

Journal

JOURNAL OF BONE AND MINERAL METABOLISM
Volume 37, Issue 1, Pages 9-17

Publisher

SPRINGER JAPAN KK
DOI: 10.1007/s00774-018-0971-7

Keywords

Sclerostin; Bone remodeling; Osteocytes; Osteoblasts; Osteoclasts

Funding

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan [18H02980, 16H02691, 18H05388]
  2. Grants-in-Aid for Scientific Research [18H02980, 16H02691, 18H05388] Funding Source: KAKEN

Ask authors/readers for more resources

Osteocytes are embedded in bone matrices and are connected to each other to respond to mechanical loading on bone. Recent studies have demonstrated the roles of mechanical loading in bone accrual. Bone responds to mechanical loading by decreasing the expression of sclerostin, an inhibitor of Wnt/-catenin signals, in osteocytes. This increases bone mass because the activation of Wnt/-catenin signals in bone microenvironments promotes bone formation and suppresses bone resorption. Thus, in recent years, sclerostin have attracted increasing attention in bone metabolism. However, the regulatory mechanism of sclerostin expression during bone remodeling has not been fully elucidated. In this review, we summarized the regulation of bone formation and resorption by Wnt signals, a Wnt/-catenin signal inhibitor sclerostin, and molecular mechanisms by which the expression of sclerostin is suppressed by mechanical loading and parathyroid hormone. We also discuss a possibility that osteoclasts suppress the expression of sclerostin during bone remodeling, which in turn, promote bone formation. The effectiveness of an anti-sclerostin antibody with anti-dickkopf-1 antibody for increasing bone mass was discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Blockade of the angiotensin II type 1 receptor increases bone mineral density and left ventricular contractility in a mouse model of juvenile Paget disease

Toshihiro Tsuruda, Taro Funamoto, Nobuyuki Udagawa, Syuji Kurogi, Yuko Nakamichi, Masanori Koide, Etsuo Chosa, Yujiro Asada, Kazuo Kitamura

EUROPEAN JOURNAL OF PHARMACOLOGY (2019)

Review Biochemistry & Molecular Biology

The Regulation of Bone Metabolism and Disorders by Wnt Signaling

Kazuhiro Maeda, Yasuhiro Kobayashi, Masanori Koide, Shunsuke Uehara, Masanori Okamoto, Akihiro Ishihara, Tomohiro Kayama, Mitsuru Saito, Keishi Marumo

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Multidisciplinary Sciences

Sclerostin expression in trabecular bone is downregulated by osteoclasts

Masanori Koide, Teruhito Yamashita, Kohei Murakami, Shunsuke Uehara, Keigo Nakamura, Midori Nakamura, Mai Matsushita, Toshiaki Ara, Hisataka Yasuda, Josef M. Penninger, Naoyuki Takahashi, Nobuyuki Udagawa, Yasuhiro Kobayashi

SCIENTIFIC REPORTS (2020)

Review Endocrinology & Metabolism

Osteoclast differentiation by RANKL and OPG signaling pathways

Nobuyuki Udagawa, Masanori Koide, Midori Nakamura, Yuko Nakamichi, Teruhito Yamashita, Shunsuke Uehara, Yasuhiro Kobayashi, Yuriko Furuya, Hisataka Yasuda, Chie Fukuda, Eisuke Tsuda

Summary: Osteoclasts and osteoblasts play essential roles in bone remodeling, with the regulation of RANKL and OPG expression being a key mechanism. The balance between these factors is crucial for maintaining bone density and preventing bone loss.

JOURNAL OF BONE AND MINERAL METABOLISM (2021)

Article Immunology

Effector memory CD4+T cells in mesenteric lymph nodes mediate bone loss in food-allergic enteropathy model mice, creating IL-4 dominance

Aiko Ono-Ohmachi, Satoki Yamada, Satoru Uno, Masato Tamai, Kohei Soga, Shotaro Nakamura, Nobuyuki Udagawa, Yuko Nakamichi, Masanori Koide, Yoshikazu Morita, Tomohiro Takano, Takumi Itoh, Shigeru Kakuta, Chikao Morimoto, Shuji Matsuoka, Yoichiro Iwakura, Michio Tomura, Hiroshi Kiyono, Satoshi Hachimura, Haruyo Nakajima-Adachi

Summary: This study highlights the specific inflammatory relationship between MLNs and bone in food-allergic enteropathy, mediated by Th2-dominant-OVA-specific T cells and IL-4 production. Inhibition of IL-4 can reduce bone loss in EW-fed mice.

MUCOSAL IMMUNOLOGY (2021)

Article Endocrinology & Metabolism

Characterization, pharmacokinetics, and pharmacodynamics of anti-Siglec-15 antibody and its potency for treating osteoporosis and as follow-up treatment after parathyroid hormone use

Eisuke Tsuda, Chie Fukuda, Akiko Okada, Tsuyoshi Karibe, Yoshiharu Hiruma, Nana Takagi, Yoshitaka Isumi, Tomomaya Yamamoto, Tomoka Hasegawa, Shunsuke Uehara, Masanori Koide, Nobuyuki Udagawa, Norio Amizuka, Seiichiro Kumakura

Summary: It has been established that Siglec-15 plays a role in osteoclast differentiation and/or function, and therapies targeting Siglec-15 can potentially treat bone diseases like osteoporosis. Researchers have produced a rat monoclonal anti-Siglec-15 antibody (32A1) and a humanized monoclonal anti-Siglec-15 antibody (DS-1501a) derived from 32A1. Studies have shown that DS-1501a specifically binds to Siglec-15 and effectively inhibits osteoclast differentiation. In animal models, DS-1501a has demonstrated the ability to inhibit bone resorption markers and maintain bone mineral density, making it a promising candidate for osteoporosis treatment.
Article Endocrinology & Metabolism

Inhibitor of protein kinase N3 suppresses excessive bone resorption in ovariectomized mice

Shunsuke Uehara, Hideyuki Mukai, Teruhito Yamashita, Masanori Koide, Kohei Murakami, Nobuyuki Udagawa, Yasuhiro Kobayashi

Summary: The study suggests Pkn3 as a potential therapeutic target for treating bone loss. The p38 MAPK inhibitor SB202190 inhibits osteoclast function by suppressing the formation of resorption pits and actin rings. SB202190 also attenuates bone loss induced by ovariectomy.

JOURNAL OF BONE AND MINERAL METABOLISM (2022)

Review Biochemistry & Molecular Biology

Positive and Negative Regulators of Sclerostin Expression

Rina Iwamoto, Masanori Koide, Nobuyuki Udagawa, Yasuhiro Kobayashi

Summary: Sclerostin inhibits bone formation by suppressing the Wnt/β-catenin signaling pathway and plays a crucial role in maintaining bone mass. The expression of sclerostin is regulated by various factors, which in turn govern bone metabolism.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cardiac & Cardiovascular Systems

Angiotensin II Induces Aortic Rupture and Dissection in Osteoprotegerin-Deficient Mice

Toshihiro Tsuruda, Atsushi Yamashita, Misa Otsu, Masanori Koide, Yuko Nakamichi, Yoko Sekita-Hatakeyama, Kinta Hatakeyama, Taro Funamoto, Etsuo Chosa, Yujiro Asada, Nobuyuki Udagawa, Johji Kato, Kazuo Kitamura

Summary: This study found that osteoprotegerin protects against aortic rupture and dissection in Ang II-induced hypertension by inhibiting receptor activator of nuclear factor-kappa B ligand activity and periostin expression.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Article Endocrinology & Metabolism

Evidence for the major contribution of remodeling-based bone formation in sclerostin-deficient mice

Masanori Koide, Teruhito Yamashita, Keigo Nakamura, Hisataka Yasuda, Nobuyuki Udagawa, Yasuhiro Kobayashi

Summary: This study found that approximately two-thirds of bone formation is remodeling-based in Sost-deficient mice, while remodeling-based bone formation accounts for most of the bone formation in Sost(+/-) mice. Anti-RANKL antibody may be useful for detecting modeling-based bone formation on trabecular bone.
Meeting Abstract Endocrinology & Metabolism

Osteoclasts promote trabecular bone formation through the suppression of sclerostin expression

Masanori Koide, Yasuhiro Kobayashi, Teruhito Yamashita, Shunsuke Uehara, Naoyuki Takahashi, Nobuyuki Udagawa, Kohei Murakami, Hisataka Yasuda

JOURNAL OF BONE AND MINERAL RESEARCH (2019)

Meeting Abstract Endocrinology & Metabolism

Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) plays important roles in the induction of both bone-resorhing activity of osteoclasts and osteoblast differentiation

Nobuyuki Udagawa, Masanori Koide, Shunsuke Uehara, Atsushi Arai, Toshihide Mizoguchi, Teruhito Yamashita, Midori Nakamura, Yasuhiro Kobayashi, Naoyuki Takahashi, Seiichiro Kumakura, Chie Fukuda, Eisuke Tsuda

JOURNAL OF BONE AND MINERAL RESEARCH (2018)

Meeting Abstract Endocrinology & Metabolism

Anti-Siglec-15 antibody inhibits bone-resorbing activity of osteoclasts and stimulates osteoblast differentiation

Nobuyuki Udagawa, Shunsuke Uehara, Masanori Koide, Atsushi Arai, Toshihide Mizoguchi, Midori Nakamura, Yasuhiro Kobayashi, Naoyuki Takahashi, Chie Fukuda, Eisuke Tsuda

JOURNAL OF BONE AND MINERAL RESEARCH (2017)

No Data Available